Read more
Health policy in India has suffered a form of austerity which makes public expenditure extremely slim. Going by recent history, India had the lowest drug prices in the world making drugs available to the impoverished population. However after the conclusion of the Uruguay rounds of GATT and the formation of WTO, India had to bring their patent law in line with the requirements of TRIPS, which meant introducing product patent instead of process patent, which was till date not permitted, keeping drug prices low. The research at hand attempts to discuss the various conceptual and practical aspects of the effect of the change in the patent regime in India and how it has and might affect industry policies and as a result availability of drugs in India, especially for the poverty stricken population. The study herein shall shed light on how public policy, business strategies, and welfare affect each other and discuss the economic and political aspects of this connection. It would be useful for those attempting to understand this connection and its conceptual underpinnings.
About the author
Rajat Shubhro Mukherjee began his career as a Law professional, before moving into the public policy domain. His area of expertise include Government Process Reforms, Health Policy, and Tech based Development Planning. He has been involved in Anti-Human Trafficking research, Rural Livelihoods Development, and Financial Inclusion in Rural Economy.
